Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M.
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis.
Kechagias KS, Kalliala I, Bowden SJ, Athanasiou A, Paraskevaidi M, Paraskevaidis E, Dillner J, Nieminen P, Strander B, Sasieni P, Veroniki AA, Kyrgiou M.
BMJ. 2022 Aug 3;378:e070135. doi: 10.1136/bmj-2022-070135.
Digital analysis and quantitative assessment of the cervical surface with dysplasia.
Dushkin AD, Afanasiev MS, Zatevalov AM, Aleshkin VA, Mironov AY, Afanasiev SS, Nesvizhsky YV, Borisova OY, Grishacheva TG, Karaulov AV.
Klin Lab Diagn. 2021 Jul 16;66(7):417-421. doi: 10.51620/0869-2084-2021-66-7-417-421.
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL Jr, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, Johnson CS, Alberts DS.
J Natl Cancer Inst. 1994 Apr 6;86(7):539-43. doi: 10.1093/jnci/86.7.539.
Cytomorphometric differences among individual "moderate dysplasia" cells derived from cervical intraepithelial neoplasia.
Rosenthal DL, Suffin SC, Missirlian N, McLatchie C, Castleman KR.
Anal Quant Cytol. 1984 Sep;6(3):189-95.
Cervical dysplasia and human papillomavirus.
Carmichael JA, Maskens PD.
Am J Obstet Gynecol. 1989 Apr;160(4):916-8. doi: 10.1016/0002-9378(89)90310-4.
Laser miniconization procedure.
Békássy Z.
Int J Gynaecol Obstet. 1996 Dec;55(3):237-46. doi: 10.1016/s0020-7292(96)02767-1.
Inner border--a specific and significant colposcopic sign for moderate or severe dysplasia (cervical intraepithelial neoplasia 2 or 3).
Scheungraber C, Glutig K, Fechtel B, Kuehne-Heid R, Duerst M, Schneider A.
J Low Genit Tract Dis. 2009 Jan;13(1):1-4. doi: 10.1097/LGT.0b013e31817ff92a.
Evaluation of mild-to-moderate dysplasia on cervical-endocervical (Pap) smear: a subgroup of patients who bridge LSIL and HSIL.
McGrath CM, Kurtis JD, Yu GH.
Diagn Cytopathol. 2000 Oct;23(4):245-8. doi: 10.1002/1097-0339(200010)23:4<245::aid-dc6>3.0.co;2-7.
[Cervical dysplasia].
Tabachnik BI, Nikitina MA.
Vopr Onkol. 1984;30(3):21-8.
